Articles

AZ’s COVID-19 jab sales top $1.2bn, but come at a loss

AstraZeneca said this morning that it has made $1.2 billion in sales from its COVID-19 vaccine Vaxzevria in the first half of this year, but making it available at no profit had weighed on its profit margins. R&D expenses leaped 28% in the period, an increase that AZ said was “primarily” a result of its …

AZ’s COVID-19 jab sales top $1.2bn, but come at a loss Read More »

Viatris and Biocon’s Semglee (biosimilar, insulin glargine) Receive the US FDA’s Approval as the First Interchangeable Biosimilar for Diabetes

Shots: The US FDA has approved Semglee (insulin glargine-yfgn injection) as the first interchangeable biosimilar product under the 351(k) regulatory pathways to treat diabetes Semglee will allow pharmacy level substitution for the reference product, Lantus across the US & will be launch before the end of 2021. Biocon is eligible to have exclusivity for 12mos. …

Viatris and Biocon’s Semglee (biosimilar, insulin glargine) Receive the US FDA’s Approval as the First Interchangeable Biosimilar for Diabetes Read More »

Democrats consider scaling back new funds to fight next pandemic

Congressional Democrats are considering cutting new funds for pandemic preparedness in an upcoming package from the $30 billion proposed by President Biden to as little as $5 billion, sources say, prompting alarm from public health advocates.As…

3 Ways IoT is Empowering Modern Healthcare Industry Today

Ajay Rane, VP of Global Ecosystem Development, Sigfox Today’s healthcare systems are nothing like their predecessors of even a decade ago, and their growth is due, in large part, to the rapid evolution of technology. In recent years, e-health—the digital services that make it possible to improve the well-being of individuals, whether to prevent, diagnose …

3 Ways IoT is Empowering Modern Healthcare Industry Today Read More »

FDA okays Mylan insulin drug as first ‘interchangeable’ biosimilar

Generic drugmaker Mylan has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi’s once-daily insulin Lantus. Mylan’s Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in …

FDA okays Mylan insulin drug as first ‘interchangeable’ biosimilar Read More »

Pfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales

Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs. By making prohibitively expensive medicine essentially free for patients, the company induced them to use Pfizer drugs even as the price of one of those medicines, …

Pfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales Read More »

Covid Renews Interest in Radiation, but Docs Caution Against Pilgrimages to Radon-Filled Mines

BOULDER, Mont. — Twice a year, Brian Tichenor makes the 1,200-mile drive each way from his home in Kansas to a defunct uranium mine in Montana, where he takes an elevator 85 feet below the surface to sit amid radioactive radon gas to ease the pain from his chronic eye condition. “I found it like …

Covid Renews Interest in Radiation, but Docs Caution Against Pilgrimages to Radon-Filled Mines Read More »

Olympic Dream Dashed After Bike Crash and Nightmare Medical Bill Over $200K

It was a race in Pennsylvania that could have sent cyclist Phil Gaimon to the Tokyo Olympics; instead, a serious crash landed the Californian in two hospitals on the East Coast. Gaimon knows accidents are, unfortunately, part of the sport. He had retired from competitive road cycling three years earlier, but a recruiting call came …

Olympic Dream Dashed After Bike Crash and Nightmare Medical Bill Over $200K Read More »

Regeneron and Sanofi Report Results of Dupixent (dupilumab) in P-III LIBERTY CUPID Clinical Program for Chronic Spontaneous Urticaria

Shots: The study A of P-III LIBERTY CUPID trial evaluates Dupixent vs SoC in 138 patients aged ≥6 yrs. with CSU who remained symptomatic despite antihistamine use and who were not previously treated with anti-IgE therapeutics The trial met its 1EPs & 2EPs @24wks. i.e. showed a reduction in itch severity (63% vs 35%), reduction …

Regeneron and Sanofi Report Results of Dupixent (dupilumab) in P-III LIBERTY CUPID Clinical Program for Chronic Spontaneous Urticaria Read More »

Technology and empathy help make remote working a success for Elsevier

We at Elsevier were pleased to be one of five companies recognized for their ability to keep remote workers rooted in company culture in this recent Comparably article. Like many organizations during the pandemic, we had to quickly adapt to remote working on a large scale for our international workforce. As the article notes, “Elsevier …

Technology and empathy help make remote working a success for Elsevier Read More »

PharmaShots Celebrates Successful Accomplishment of Three Years

Shots: PharmaShots has started its journey in July 2018 as a concise, real-time news delivery platform and is proud to announce the completion of three years, with many more to come. Till now, PharmaShots has published 5,000+ posts with 10000+ subscribers With the completion of three years journey, PharmaShots is proud to announce the “PharmaShots …

PharmaShots Celebrates Successful Accomplishment of Three Years Read More »

Roche Reports the US FDA’s Acceptance of BLA for Faricimab to Treat Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

Shots: The BLA submission is based on four P-III studies i.e TENAYA, LUCERNE, YOSEMITE & RHINE evaluating the efficacy & safety of faricimab vs aflibercept in patients with nAMD & DME. The LTE studies for faricimab are underway The studies demonstrated non-inferior visual acuity gains and greater reductions in CST, ~50% of patients can extend …

Roche Reports the US FDA’s Acceptance of BLA for Faricimab to Treat Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration Read More »

Pharma firm Advanz fined after thyroid drug price hike of 6,000%

CMA found company’s ‘excessive and unfair’ prices cost NHS almost £30m extra over 10 years The UK’s competition watchdog has imposed fines of more than £100m on the pharmaceutical company Advanz and its former private equity owners after it was found to have inflated the price of its thyroid tablets by up to 6,000%. An …

Pharma firm Advanz fined after thyroid drug price hike of 6,000% Read More »

BD Acquires Tepha to Boost its Surgical Mesh Portfolio

Shots: The acquisition will utilize Tepha’s resorbable polymer technology to boost the growth of BD’s surgical mesh portfolio for the repair and regeneration of soft tissues The acquisition also provides strategic vertical integration for BD’s Phasix mesh products & includes Tepha’s GalaFLEX portfolio which is based on the novel P4HB polymer Additionally, an interventional segment …

BD Acquires Tepha to Boost its Surgical Mesh Portfolio Read More »

Further extension of the Greater Sydney Hotspot for Commonwealth Support

The Australian Government Acting Chief Medical Officer, Professor Michael Kidd, has extended the COVID-19 Hotspot for the purposes of Commonwealth support for Greater Sydney, including the Blue Mountains, Central Coast, Shellharbour and Wollongong, until 28 August 2021.

After suspending EUA request, Brazil now shelves import authorisation of Covaxin

According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa its Collegiate Board on Tuesday took a decision to suspend the exceptional and temporary authorisation for import and distribution of Covaxin after Bharat Biotech informed the South America government about the termination of its pact with its Brazilian partners.

Medicare vaccine coverage (including how the COVID-19 vaccines are covered)

How does Medicare cover vaccines? Are the paid for by Medicare Part B or Part D? MedPAC’s June 2021 report provides a nice overview. Medicare covers vaccines under Part B and Part D. Part B covers vaccines for influenza, pneumococcal disease, hepatitis B (for patients at high or intermediate risk), and coronavirus disease 2019 (COVID-19), …

Medicare vaccine coverage (including how the COVID-19 vaccines are covered) Read More »

“Healthy workers, thriving companies – a practical guide to wellbeing at work” – language versions now available

29/07/2021 “Healthy workers, thriving companies – a practical guide to wellbeing at work” – language versions now available Our “Healthy workers, thriving companies practical guide to wellbeing at work” presents a hands-on approach to preventing and managing work-related psychosocial risks and musculoskeletal disorders. European workers report these two issues as the…

Ring Therapeutics rounds up $117M to find better viral vectors for gene therapy

The engineered viruses used to deliver gene therapies can spark complications and they can’t be re-dosed. Ring Therapeutics says viruses that evolved with humans can be better viral vectors and the startup has raised $117 million in new financing to continue its research.

Overnight Health Care: Biden expected to announce vaccine requirement for federal workers | Republican governors revolt against CDC guidance | Pfizer: Third vaccine shot ‘strongly’ boosts immune response against delta

Welcome to Wednesday’s Overnight Health Care. Senate Minority Leader Mitch McConnell is running pro-vaccine ads across Kentucky, using money from his reelection campaign. If you have any tips, email us at nweixel@thehill.com, psullivan@…

Medicare Enrollment Starting to Accelerate, as Number of Home Health Agencies Continues to Decline

Enrollment in fee-for-service (FFS) Medicare has started to accelerate in recent years, as more members of the baby-boom generation age into the program. At the same time, the number of individual home health agencies in the U.S. continues to decline. That’s according to the Medicare Payment Advisory Commission (MedPAC), which reported on emerging Medicare trends …

Medicare Enrollment Starting to Accelerate, as Number of Home Health Agencies Continues to Decline Read More »

Amwell Acquires Conversa Health & SilverCloud Health – M&A

What You Should Know: – Amwell®, a telehealth leader, today announced that it has signed definitive agreements to acquire SilverCloud Health, a leading digital mental health platform, and Conversa Health, a leader in automated virtual healthcare. – By adding the technology of these two companies to its virtual care platform, Amwell is greatly enhancing the …

Amwell Acquires Conversa Health & SilverCloud Health – M&A Read More »

Encompass CEO Mark Tarr: Home Health Separation Will Enhance Long-Term Business Value

Those interested in what Encompass Health Corporation (NYSE: EHC) will do next with its home health and hospice segment have been largely left to read the tea leaves up to this point. And while there is still not a final conclusion, the company is on the verge of completing its exploration of “strategic alternatives” for …

Encompass CEO Mark Tarr: Home Health Separation Will Enhance Long-Term Business Value Read More »

11th Annual Global Summit on Regulatory Science – 10/04/2021 – 10/06/2021

Information about the Virtual 2021 Global Summit on Regulatory Science (GSRS21) – Title: 11th Annual Global Summit on Regulatory Science Conference (GSRS21); Theme: Regulatory Sciences for Food/Drug Safety with Real-World Data & Artificial Intelligence (AI); Question & Answer Sessions; October 4-6, 2021

SonderMind Raises $150M to Expand Tech-Enabled Behavioral Health Platform

What You Should Know: – SonderMind Inc., a Denver, CO-based provider in improving mental health clinical outcomes and making behavioral health more accessible to all Americans, today announced it has raised $150M in Series C financing co-led by new investors Drive Capital and Premji Invest, with participation from General Catalyst, Partners Group, Smash Ventures, Kickstart, and …

SonderMind Raises $150M to Expand Tech-Enabled Behavioral Health Platform Read More »

Humana Sets Stage for Kindred Takeover, Remains Hopeful About a 2022 Return to Normalcy

Despite still reeling from COVID-19-related headwinds, Humana Inc. (NYSE: HUM) experienced better-than-expected results in its home and provider businesses during the second quarter of 2021. “Our strong operating performance this year is, in part, attributed to our strong partnerships with providers who are delivering high-quality care to our members,” Bruce Broussard, president and CEO of …

Humana Sets Stage for Kindred Takeover, Remains Hopeful About a 2022 Return to Normalcy Read More »

Scientists advance breast, ovarian cancer research with cryo-electron microscopy

Using advanced imaging technology, scientists have provided an unprecedented understanding of the BRCA1-BARD1 protein complex, which is often mutated in patients with breast or ovarian cancer. Their paper identifies aspects of how BRCA1-BARD1 functions, supporting future translational research, cancer prevention efforts and drug development.

Los Angeles uses emergency alert system to push COVID-19 vaccines

The city of Los Angeles on Wednesday used its emergency alert system to urge local residents to get vaccinated as officials express growing concern over a new surge in cases due in part to the highly transmissible delta variant. Multiple LA-…

Seeking a unique treatment for lobular breast cancer

In an attempt to find out why the long-term outcomes are poorer for patients with lobular breast cancer — which affects some 40,000 women a year — researchers began looking at the role of the protein MDC1 in tumor cells.

AI-driven Deep Genomics gets $180M to turn biology into informational medicines

Softbank led the Series C round of funding for Deep Genomics, a startup that applies its artificial intelligence technology to all aspects of discovering and developing new drugs. The Deep Genomics platform has yielded 10 programs; CEO Brendan Frey aims to advance four of them to the clinic in two years, all while tripling the …

AI-driven Deep Genomics gets $180M to turn biology into informational medicines Read More »

Here’s where you should wear a mask indoors under new CDC guidace

The Centers of Disease Control and Prevention (CDC) on Tuesday released updated guidance that recommended many Americans again wear masks when they venture into indoor public spaces such as grocery stores, theaters and arenas.The update came amid an…

Pfizer hikes COVID vaccine sales forecast for 2021 to $33.5bn

Continuing orders for Pfizer’s BioNTech-partnered COVID-19 vaccine Comirnaty have prompted near one-third increase in its projected revenues for the vaccine this year, from $26 billion to $33.5 billion. It’s a big increase, considering the former figure was the drugmaker’s best guess just three months ago, and takes into account additional supply agreement signed from mid-April …

Pfizer hikes COVID vaccine sales forecast for 2021 to $33.5bn Read More »

DHS imposes mask mandate for employees

All employees at the Department of Homeland Security (DHS) will be required to wear masks indoors and physically distance beginning on Wednesday, regardless of their vaccination status, Reuters reported.The new mandate was issued a day…

Republican governors revolt against CDC mask guidance

Republican governors are rejecting new mask recommendations the Centers for Disease Control and Prevention issued Tuesday, casting the health guidance as a step back amid a push to vaccinate millions of Americans that is already struggling in their…

Hearts from donors who used illicit drugs or overdosed safe for transplant, cuts wait time

Tragically, the opioid epidemic has led to an increase in accidental and premature deaths, which has also increased the number of hearts available for potential organ donation. Receiving a heart from a donor who used illicit drugs does not impact the recipient’s survival, according to a group of researchers from Virginia, Arizona and Indiana.

Mental Health Startup SonderMind Lands $150M to Tackle ‘THE’ Health Issue of Our Generation

By JESSICA DaMASSA, WTF HEALTH SonderMind closes a $150M Series C funding round co-led by Drive Capital and Premji Invest, and we get CEO Mark Frank’s take on what sets THIS digital mental health startup apart from a pack of very well-funded competitors. SonderMind has its own behavioral health therapists, built its own tech stack, …

Mental Health Startup SonderMind Lands $150M to Tackle ‘THE’ Health Issue of Our Generation Read More »

Lacking Dental Coverage, Many People on Medicare Forgo Dental Care, Especially Beneficiaries of Color

Many people enrolled in Medicare go without dental care, especially beneficiaries of color, according to a new KFF analysis of dental coverage and costs for people with Medicare. Almost half of all Medicare beneficiaries (47%) did not have a dental visit within the past year as of 2018, the analysis finds, with rates higher among…More

Lessons from the first generation of cell and gene oncology trials

Advances in cell and gene science are paving the way for transformative cancer treatments, but there are still many complexities in delivering clinical trials for these therapies. ICON’s Tamie Joeckel and Brandon Fletcher take us through best-practice approaches to CGT studies and discuss what the future could hold for this exciting area. Cell and gene …

Lessons from the first generation of cell and gene oncology trials Read More »

Tokyo sets all-time high for new virus cases amid Olympics

Tokyo on Wednesday hit an all-time high for new coronavirus infections with more than 3,000 reported as Japan’s capital remains under a state of emergency with the Olympic Games in full swing. Tokyo recorded 3,177 new COVID-19 cases on…

Medicare and Dental Coverage: A Closer Look

Medicare does not cover routine dental care and about half of Medicare beneficiaries do not have dental coverage. Some beneficiaries have dental coverage through other sources, including Medicare Advantage, but 47% of all beneficiaries have not been to the dentist in the past year and many older adults face high out-of-pocket costs for needed dental …

Medicare and Dental Coverage: A Closer Look Read More »

Recognizing Hepatitis R&D on World Hepatitis Day

Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. There are five main hepatitis viruses, with types A, B, C most common. In 2018, the Centers for Disease Control and Prevention estimated that Americans were infected with 24,900 cases of hepatitis A and 21,600 cases of hepatitis B, many of …

Recognizing Hepatitis R&D on World Hepatitis Day Read More »

WHO says COVID-19 deaths up 21 percent globally in last week

COVID-19 deaths have increased by 21 percent globally in the last week, according to the World Health Organization (WHO).The majority of the 69,000 deaths were recorded in the Americas and Southeast Asia, according to The Associated Press.The WHO…

Unraveling the Mysterious Mutations That Make Delta the Most Transmissible Covid Virus Yet

Upon first inspection, the mutations in the highly contagious delta covid variant don’t look that worrisome. For starters, delta has fewer genetic changes than earlier versions of the coronavirus. “When people saw that the epidemic in India was driven by delta, they did not suspect it would be so bad or overtake other variants,” said …

Unraveling the Mysterious Mutations That Make Delta the Most Transmissible Covid Virus Yet Read More »

Opportunity Trifecta: ISA, SVAP and Draft USCDI Version 3 Feedback Period Now Open

On the heels of the release of United States Core Data for Interoperability USCDI Version 2 (USCDI v2), ONC has also opened a single, synchronized feedback period for the Interoperability Standards Advisory(ISA), the Standards Version Advancement Process (SVAP), and the draft United States Core Data for Interoperability Version 3 (USCDI v3). Taken together, ISA, SVAP, and …

Opportunity Trifecta: ISA, SVAP and Draft USCDI Version 3 Feedback Period Now Open Read More »

Man charged with threatening Fauci, NIH director

A man has been charged with threatening Dr. Anthony Fauci, President Biden’s chief medical adviser, and Dr. Francis Collins, the director of the National Institutes of Health (NIH).Thomas Patrick Connally, Jr., 56, was charged on Tuesday with…

Gottlieb: US will be through delta wave in 2 or 3 weeks

Former Food and Drug Administration Commissioner Scott Gottlieb predicted early Wednesday that the United States could get through the worst of the delta variant surge of the coronavirus in a few weeks. “The bottom line is, the…

Ford again requiring masks at plants in Missouri, Florida

The Ford Motor Company said it will again require all employees to wear masks at its facilities in Missouri in Florida, two states where new coronavirus cases are spiking. The mandate will be in effect for visitors at Ford’s Missouri…

BridgeBio Enters into Clinical Collaboration with BMS to Evaluate BBP-398 + Opdivo for Advanced Solid Tumors with KRAS Mutations

Shots: The companies will initiate P-I/II study evaluating the safety and preliminary efficacy of BBP-398 in combination with both Opdivo as dual therapy & Opdivo + KRASG12C inhibitor as triplet therapy in NSCLC patients with KRAS mutations, as 1L & 2L treatment options BridgeBio will sponsor the study while BMS will provide nivolumab to the …

BridgeBio Enters into Clinical Collaboration with BMS to Evaluate BBP-398 + Opdivo for Advanced Solid Tumors with KRAS Mutations Read More »

AZ says second COVID jab dose isn’t linked to rare clot reaction

A new analysis has suggested that the rare blood clot side effects linked to AstraZeneca’s COVID-19 vaccine Vaxzevria don’t occur after a second dose. The study in The Lancet examined cases of thrombosis with thrombocytopenia syndrome (TTS) from an AZ database encompassing around 5.62 million people who had received two doses of Vaxzevria in the …

AZ says second COVID jab dose isn’t linked to rare clot reaction Read More »

“Healthy workers, thriving companies – a practical guide to wellbeing at work” – language versions now available

Back to news 29/07/2021 “Healthy workers, thriving companies – a practical guide to wellbeing at work” – language versions now available Our “Healthy workers, thriving companies practical guide to wellbeing at work” presents a hands-on approach to preventing and managing work-related psychosocial risk s and musculoskeletal disorders. European workers report these two issues as the…See …

“Healthy workers, thriving companies – a practical guide to wellbeing at work” – language versions now available Read More »

Home Health CEO Barb Jacobsmeyer Hits the Ground Running, as Encompass Confirms Separation Plans

Barb Jacobsmeyer is the new head of Encompass Health’s (NYSE: EHC) home health and hospice segment, taking over following the departure of former CEO and founder April Anthony. Previously the head of the Birmingham, Alabama-based company’s in-patient hospitals segment, Jacobsmeyer takes the helm at a point when Encompass Health is on the verge of a …

Home Health CEO Barb Jacobsmeyer Hits the Ground Running, as Encompass Confirms Separation Plans Read More »

Why digital doctors are crucial for the future of primary care

Our primary care system is weathering a storm on several fronts. Demand is skyrocketing, with GPs delivering millions more appointments than in previous years and workload far outstripping pre-Covid-19 levels. Dr Dan Bunstone explores how innovation can help GPs overcome the current capacity squeeze in primary care and tackle patient backlog. Despite the misconception that general …

Why digital doctors are crucial for the future of primary care Read More »

UK’s Peppy raises £6.6m for workplace digital health platform

A £6.6 million ($9.2 million) cash injection for UK digital health company Peppy will be used to scale up its business-to-business platform and expand its reach and range of services. The Series A financing, led by Felix Capital, will help the company reach more organisations and people in the UK, and also allow it to …

UK’s Peppy raises £6.6m for workplace digital health platform Read More »

Martin Shkreli’s $7.4m forfeit is paid, thanks to that Wu-Tang Clan album

The US government has sold off the one-of-a-kind Wu-Tang Clan album famously bought by ‘pharma bro’ Martin Shkreli, with the proceeds enough to wipe out his $7.4 million fine for defrauding investors. Shkreli, the pharma entrepreneur who became notorious in 2015 for hiking the price of a lifesaving drug, bought the Once Upon a Time …

Martin Shkreli’s $7.4m forfeit is paid, thanks to that Wu-Tang Clan album Read More »

Martin Shkreli’s $7.4m forfeit is paid, thanks to that Wu-Tang Clan album

The US government has sold off the one-of-a-kind Wu-Tang Clan album famously bought by ‘pharma bro’ Martin Shkreli, with the proceeds enough to wipe out his $7.4 million fine for defrauding investors. Shkreli, the pharma entrepreneur who became notorious in 2015 for hiking the price of a lifesaving drug, bought the Once Upon a Time …

Martin Shkreli’s $7.4m forfeit is paid, thanks to that Wu-Tang Clan album Read More »

AbbVie, Calico raise their age-related disease alliance funding to $3.5bn

AbbVie and Alphabet spin-out Calico Life Sciences have agreed to fund their seven-year-old partnership seeking treatments for diseases of ageing with another $500 million apiece. The collaboration with Google sister company Calico – formed in 2014 with $1.5 billion in funding and extended in 2018 with another $1 billion top up – has already resulted …

AbbVie, Calico raise their age-related disease alliance funding to $3.5bn Read More »

AbbVie, Calico raise their age-related disease alliance funding to $3.5bn

AbbVie and Alphabet spin-out Calico Life Sciences have agreed to fund their seven-year-old partnership seeking treatments for diseases of ageing with another $500 million apiece. The collaboration with Google sister company Calico – formed in 2014 with $1.5 billion in funding and extended in 2018 with another $1 billion top up – has already resulted …

AbbVie, Calico raise their age-related disease alliance funding to $3.5bn Read More »

Sign-Up Window for Free COBRA Coverage for Many Laid-Off Workers Closes This Week

After being laid off from her job as a systems analyst for a specialty chemicals company in December, Gabriela de Pompignan opted to hang on to her former employer’s insurance coverage under the federal law known as COBRA. Typically, laid-off workers pick up the total cost of premiums under COBRA, but her company paid roughly …

Sign-Up Window for Free COBRA Coverage for Many Laid-Off Workers Closes This Week Read More »

Women Say California Insurer Makes It Too Hard to Get Drug for Postpartum Depression

When Miriam McDonald decided she wanted to have another baby at age 44, her doctor told her she had a better chance of winning the lottery. So when she got pregnant right away, she and her husband were thrilled. But within three days of giving birth to their son, in September 2019, everything shifted. “I …

Women Say California Insurer Makes It Too Hard to Get Drug for Postpartum Depression Read More »

After false start, Merck claims Keytruda approval in early breast cancer

Merck & Co’s Keytruda has just picked up its 30th approval from the FDA, and it is a good one – early-stage triple-negative breast cancer (TNBC), a particularly hard-to-treat form of the disease. The FDA has given a green light to the use of Keytruda (pembrolizumab) pre-surgery alongside chemotherapy in the neoadjuvant setting, as well …

After false start, Merck claims Keytruda approval in early breast cancer Read More »

Amgen to Acquire Teneobio for ~$2.5B

Shots: Amgen to acquire all outstanding shares of Teneobio for $900M as up front and $1.6B in cash as contingent milestones to Teneobio equity holders. The transaction is expected to be closed in H2’21 The acquisition will boost Amgen’s abilities to develop innovative therapies and expand its portfolio with the addition of early-stage oncology assets …

Amgen to Acquire Teneobio for ~$2.5B Read More »

Links

Real-world cost of health interventions. Looks and career success. Improved PubMed search.  A-APM vs. MIPS  Political alignment and tax evasion.

Mechanical Power Presses Update

[Federal Register Volume 86, (Wednesday, July 28, 2021 )] [Notice] [Pages 40651-40659] Mechanical Power Presses Update

Top health official sees various routes to lowering patient costs

Meena Seshamani, director of the Center for Medicare, said drug companies, health care providers and the government need to do more for Americans who struggle to afford prescription drugs.Speaking at The Hill’s “Making Medicare Work Better for…

Employers have legal right to mandate COVID shots

The U.S. Department of Veterans Affairs. The state of California. New York City. Hospitals and nursing homes. Colleges and universities. Employers are putting COVID-19 vaccine mandates into place and it’s getting attention.

Don’t fool around with syphilis

A national campaign launches to raise awareness of the sexually transmissible infection (STI) syphilis and the current outbreak happening across Australia.

Amgen adds antibody assets and R&D tech with $900M Teneobio acquisition

Amgen is paying $900 million up front to acquire Teneobio, a biotech with technology for discovering and developing antibody drugs. Though Amgen already has its own antibody platform, the company says Teneobio’s technology and drug assets will complement its own.

CDC backtracks with new mask guidance

The Centers for Disease Control and Prevention (CDC) on Tuesday reversed guidance from just two months ago by saying fully vaccinated people should now mask up in certain areas, underscoring the growing threat posed by a new strain of the…

ModivCare CEO on $340M CareFinders Deal: Our Goal Is to Build Out a National Platform

ModivCare Inc. (NYSE: MODV), the non-emergency medical transportation (NEMT) company that’s quickly becoming a major player in the home-based care space as well, announced Monday plans to buy CareFinders Total Care for $340 million. Once the deal is finalized, ModivCare will initially combine the CareFinders business with its existing personal care capabilities from Simplura Health …

ModivCare CEO on $340M CareFinders Deal: Our Goal Is to Build Out a National Platform Read More »

Health Care Associations Call for Vaccine Mandate as Threat of the Delta Variant Grows

A number of major medical groups and senior services associations have joined forces to call for mandatory COVID-19 vaccinations for all health and long-term care workers. This national push for a mandate comes at a time when a new and more infectious strain of coronavirus — the Delta variant — is making the news. “The …

Health Care Associations Call for Vaccine Mandate as Threat of the Delta Variant Grows Read More »

West Virginia opioids lawsuit comes to a close

Three major U.S. drug distributors should be held responsible for sending a “tsunami” of prescription pain pills that caused a health crisis in one corner of West Virginia, an attorney for local governments said in closing arguments.

New strategy for drug design: Keeping copper atoms closer to keep bacteria away

Hydrogen peroxide reacts with copper to produce hydroxyl radicals with strong antibacterial properties. However, this requires high copper concentrations because two copper atoms have to come close together, which occurs by chance. Now, scientists have engineered a long polymer with copper-containing side units that create regions with locally high copper density, boosting the antibacterial activity …

New strategy for drug design: Keeping copper atoms closer to keep bacteria away Read More »

What Microsoft’s Nuance Acquisition Means for the Healthcare Industry

Microsoft agreed to acquire speech recognition and artificial intelligence company Nuance Communications for $19.7 billion in April. The acquisition establishes Microsoft as a major player in healthcare technology by bridging the gap between clinicians and Microsoft Cloud for Healthcare. The tech giant launched Cloud for Healthcare late in 2020. It includes healthcare-specific versions of Microsoft …

What Microsoft’s Nuance Acquisition Means for the Healthcare Industry Read More »

AC Immune picks up Phase 2-ready drug for Parkinson’s in $58M deal with Affiris

AC Immune is bolstering the Parkinson’s disease portion of its drug pipeline with a deal to acquire a therapeutic vaccine that Affiris is developing for the disorder. Switzerland-based AC Immune plans to advance its new asset to Phase 2 testing.

Success at a glance: Turning incomplete patient data from COVID-19 testing and vaccinations into valid reimbursable claims

“Experian Health’s speed and ability to speak our business language definitely impressed us,” said ACS president, Tim Anderson. “Some of the claims were valid for only a few more weeks, and we were able to submit them in plenty of time. This is the best, fastest platform we’ve seen to reconcile duplicate and data-deficient records. …

Success at a glance: Turning incomplete patient data from COVID-19 testing and vaccinations into valid reimbursable claims Read More »

WHO leader issues warning on ‘harmful’ e-cigarettes

The head of the World Health Organization (WHO) on Tuesday noted that while many countries have made “progress in the fight against” the “tobacco epidemic,” the marketing of e-cigarettes toward young people could have “harmful” health outcomes…

Fauci joins YouTube coronavirus special aimed at Black community

Anthony Fauci, President Biden’s chief medical adviser, kicked off a new informational YouTube series Tuesday about COVID-19 vaccines that aims to reach Black and brown communities. Fauci participated in a question-and-answer interview with two…

340B hospitals among those that provide lowest levels of community benefit across the country

The 340B program reached $38 billion in sales at the discounted price in 2020. This is a 27% increase over sales in 2019, and the program is now more than four times the size it was in 2014. Unfortunately, despite pharmaceutical manufacturers paying more and more money in 340B discounts, there is no evidence that …

340B hospitals among those that provide lowest levels of community benefit across the country Read More »

Miami ICU full with unvaccinated patients

A Miami, Fla., intensive care unit (ICU) is overflowing with unvaccinated COVID-19 patients, a local CBS affiliate reported on Tuesday.Jackson Memorial Hospital’s ICU Nurse Manager Alix Zacharski told the CBS News affiliate that the “…